Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EVEREST GROUP, LTD.EG · Entity 3370 | Director | February 26, 2026 | March 02, 2026 |
| Hippo Holdings Inc.HIPO · Entity 5057 | Director | June 02, 2026 | June 05, 2026 |
| METLIFE INCMET · Entity 488 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EVEREST GROUP, LTD.
Report date February 26, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 1,914 |
Reported balance
After 2026-02-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-26 · Grant · Acquired 960 · Balance 1,914 F1: The Common Shares are Restricted Common Shares awarded under the Company's 2003 Non-Employee Director Equity Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The Common Shares are Restricted Common Shares awarded under the Company's 2003 Non-Employee Director Equity Plan.
Hippo Holdings Inc.
Report date June 02, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,502 |
Reported balance
After 2026-06-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 2,502 · Balance 2,502 F1: Vesting/settlement of 2,502 RSUs originally granted on Oct 1, 2025 into Common Stock |
| Common StockSEC Table I · non-derivative | Direct | 7,310 |
Reported balance
After 2026-06-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-06-02 · Grant · Acquired 4,808 · Balance 7,310 F2: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting that occurs following the date of grant, subject to the Reporting Person continuing in service to the Issuer and its subsidiaries through such vesting date. F3: Includes 4,808 RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Vesting/settlement of 2,502 RSUs originally granted on Oct 1, 2025 into Common Stock
F2: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting that occurs following the date of grant, subject to the Reporting Person continuing in service to the Issuer and its subsidiaries through such vesting date.
F3: Includes 4,808 RSUs.
METLIFE INC
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,901 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 544 · Balance 6,901 F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:04 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0002013372-26-000016 · wk-form4_1791230677.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,901 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 39 | $95.50 | $3,724.50 |
DisclosureSEC source: 0002013372-26-000014 · wk-form4_1789070545.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,357 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:12 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0002013372-26-000012 · wk-form4_1781813532.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,318 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 39 | $85.57 | $3,337.23 |
DisclosureSEC source: 0002013372-26-000010 · wk-form4_1781208157.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,731 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 00:29 UTC | Hippo Holdings Inc. HIPO · Entity 5057 | GrantCommon Stock | 4,808 | $0.00 | $0.00 |
DisclosureSEC source: 0002013372-26-000008 · primarydocument.xml · nonDerivative · entry 2 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,310 F2 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting that occurs following the date of grant, subject to the Reporting Person continuing in service to the Issuer and its subsidiaries through such vesting date. F3 · balance_after: Includes 4,808 RSUs. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 00:29 UTC | Hippo Holdings Inc. HIPO · Entity 5057 | GrantCommon Stock | 2,502 | $25.40 | $63,550.80 |
DisclosureSEC source: 0002013372-26-000008 · primarydocument.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,502 F1 · shares: Vesting/settlement of 2,502 RSUs originally granted on Oct 1, 2025 into Common Stock Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:04 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 721 | $71.17 | $51,313.57 |
DisclosureSEC source: 0002013372-26-000007 · wk-form4_1775246674.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,692 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:07 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 40 | $70.60 | $2,824.00 |
DisclosureSEC source: 0002013372-26-000005 · wk-form4_1773346055.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,971 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:07 UTC | EVEREST GROUP, LTD. EG · Entity 3370 | GrantCommon Shares | 960 | $338.69 | $325,142.40 |
DisclosureSEC source: 0001628280-26-013322 · wk-form4_1772489226.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,914 F1 · security: The Common Shares are Restricted Common Shares awarded under the Company's 2003 Non-Employee Director Equity Plan. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:09 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 639 | $80.32 | $51,324.48 |
DisclosureSEC source: 0002013372-26-000003 · wk-form4_1767733789.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,931 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 21:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 31 | $77.82 | $2,412.42 |
DisclosureSEC source: 0002013372-25-000015 · wk-form4_1765486951.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,292 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:03 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 534 | $81.93 | $43,750.62 |
DisclosureSEC source: 0002013372-25-000011 · wk-form4_1759521782.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,261 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 22:15 UTC | Hippo Holdings Inc. HIPO · Entity 5057 | GrantCommon Stock | 2,502 | $0.00 | $0.00 |
DisclosureSEC source: 0002013372-25-000013 · primarydocument.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,502 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting that occurs following the date of grant, subject to the Reporting Person continuing in service to the Issuer and its subsidiaries through such vesting date. F2 · balance_after: Includes 2,502 RSUs. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 20:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 26 | $79.29 | $2,061.54 |
DisclosureSEC source: 0001099219-25-000213 · wk-form4_1757620933.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,727 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| August 20, 2025 Filed Aug 22, 2025 20:44 UTC | EVEREST GROUP, LTD. EG · Entity 3370 | GrantCommon Shares | 954 | $341.44 | $325,728.99 |
DisclosureSEC source: 0002013372-25-000006 · wk-form4_1755895450.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 954 F1 · security: The Common Shares are Restricted Common Shares awarded under the Company's 2003 Non-Employee Director Equity Plan. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:31 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 562 | $77.85 | $43,751.70 |
DisclosureSEC source: 0001099219-25-000175 · wk-form4_1750451492.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,701 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:20 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 22 | $79.43 | $1,747.46 |
DisclosureSEC source: 0001099219-25-000156 · wk-form4_1749759640.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,139 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:27 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 540 | $81.16 | $43,826.40 |
DisclosureSEC source: 0001099219-25-000112 · wk-form4_1743712042.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,116 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:18 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 18 | $78.45 | $1,412.10 |
DisclosureSEC source: 0001099219-25-000089 · wk-form4_1741897097.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,576 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000032 · wk-form4_1736199666.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,558 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 13 | $82.74 | $1,075.62 |
DisclosureSEC source: 0001099219-24-000285 · wk-form4_1734557605.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,023 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-24-000245 · wk-form4_1727986571.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,010 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:31 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 11 | $74.63 | $820.93 |
DisclosureSEC source: 0001099219-24-000221 · wk-form4_1726173109.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:37 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 627 | $69.86 | $43,802.22 |
DisclosureSEC source: 0001099219-24-000183 · wk-form4_1718915859.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,465 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:21 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 7 | $69.06 | $483.42 |
DisclosureSEC source: 0001099219-24-000165 · wk-form4_1718310105.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:23 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 594 | $73.69 | $43,771.86 |
DisclosureSEC source: 0001099219-24-000127 · wk-form4_1712175804.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 831 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 21:35 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 237 | $69.16 | $16,390.92 |
DisclosureSEC source: 0001099219-24-000042 · wk-form4_1709156131.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.